MedTrace Logo

Effects of Probiotics in Preventing Oral Mucositis

NCT03552458 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-04-30

No results posted yet for this study

Summary

The study will be a randomized double blind prospective placebo controlled clinical study and aims to determine the therapeutic efficacy of Probiotics in Oral Mucositis pathogenesis in patients undergoing head and neck radiotherapy.

Conditions

  • Head-and-neck Cancer

Interventions

DRUG

Lactobacillus Reuteri Oral Solution [BioGaia]

BioGaia Lactobacillus Reuteri drops

DRUG

Placebos

Placebo will be identical in physical appearance and color to the study agent and will be made by the manufacturer

Sponsors & Collaborators

  • National University Hospital, Singapore

    lead OTHER

Principal Investigators

  • Catherine Hong · National University Hospital, Singapore

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-26
Primary Completion
2020-12-31
Completion
2021-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03552458 on ClinicalTrials.gov